<DOC>
	<DOC>NCT00916110</DOC>
	<brief_summary>To assess the safety and tolerability of ascending single SC and IV doses of ATN-103 in healthy Japanese male subjects.</brief_summary>
	<brief_title>Study Of Single Dose Of ATN-103 Administered To Healthy Japanese Male Subjects</brief_title>
	<detailed_description />
	<criteria>Healthy Japanese male subjects aged 20 to 45 with health determined by the study investigator. BMI in the range of 17.6 to 26.4. Nonsmoker or male who smokes fewer than 10 cigarettes per day. Any significant cardiovascular, hepatic, renal, respiratory, gastrointestinal, endocrine, immunologic, dermatologic, hematologic, neurologic, or psychiatric disease. Acute disease state (eg, nausea, vomiting, infection, fever, or diarrhea) within 7 days before study day 1.</criteria>
	<gender>Male</gender>
	<minimum_age>20 Years</minimum_age>
	<maximum_age>45 Years</maximum_age>
	<verification_date>January 2013</verification_date>
	<keyword>healthy subjects</keyword>
</DOC>